Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial

Abstract Background The treatment of insomnia, which is the most common sleep disorder, includes drug and behavioral treatment, but each treatment measure has its limitations. So new treatment method needs to be taken to improve the treatment effect. MN supplementation is a potential promising new m...

Full description

Bibliographic Details

Published in:	Trials
Main Authors:	Xiangyang Gao, Junhua Li, Sanping Xu, Xueying Li, Xicheng Wang, Yongli Li, Yan Huang, Shaohui Liu, Qiang Zeng
Format:	Article
Language:	English
Published:	BMC 2023-05-01
Subjects:	Chronic insomnia Nicotinamide mononucleotide (NMN) Randomized controlled trial
Online Access:	https://doi.org/10.1186/s13063-023-07351-8